![]() | Up a level |
Zhang, Yichen, Li, Huangqianyu, Chen, Jinyu, Naci, Huseyin
ORCID: 0000-0002-7192-5751, Wagner, Anita K, Shi, Luwen and Guan, Xiaodong
(2025)
Evolution of evidence on overall survival benefits of cancer drugs included on the national reimbursement drug list of China, 2005–2022: an observational study.
BMJ Evidence-Based Medicine.
ISSN 2515-446X
Wei, Yuxuan, Zhang, Yichen, Xu, Ziyue, Wang, Guoan, Zhou, Yue, Li, Huangqianyu, Shi, Luwen, Naci, Huseyin
ORCID: 0000-0002-7192-5751, Wagner, Anita K. and Guan, Xiaodong
(2024)
Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001–2020.
The Lancet Regional Health - Western Pacific, 45.
ISSN 2666-6065